Weronika M.
- Country
- Poland
- Department
- N/A
Research Overview
- Evaluation of Clascoterone Solution Efficacy and Safety in Androgenetic Alopecia Treatment in Adult Males: A Phase 3 Randomized Double-Blind Study
- Efficacy and Safety of Povorcitinib in a 52-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial for Adult Nonsegmental Vitiligo
- A Phase 3 Study to Evaluate the Efficacy and Safety of JNJ-77242113 in Participants With Moderate to Severe Plaque Psoriasis Compared to Deucravacitinib or Placebo
Data & Insights
Has run more than one trial at 54 of 215 partner sites.
Specializations
Dermatological Conditions
This investigator specializes in researching treatments for various dermatological disorders, with a particular focus on moderate to severe plaque psoriasis and vitiligo.
- Inflammatory Skin Disorders
- Autoimmune Skin Conditions
- Skin Pigmentation Disorders
The research encompasses both segmental and nonsegmental forms of vitiligo treatment approaches.
Hair Loss Treatment
The investigator conducts research in the field of androgenetic alopecia, focusing on novel therapeutic solutions for male pattern hair loss.
- Male Pattern Hair Loss
- Topical Treatment Solutions
- Hormonal Hair Loss Therapy
Research includes evaluation of innovative topical solutions for treating pattern hair loss conditions.
Treatment Innovation
The investigator evaluates novel therapeutic compounds including ritlecitinib and povorcitinib for dermatological applications.
- Novel Therapeutic Agents
- Long-term Treatment Efficacy
- Safety Assessment Protocols
The research focuses on developing effective treatment options for chronic skin conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.